WASHINGTON (AP) — The Food and Drug Administration has approved the first hemophilia B treatment designed to decrease frequency of injections to prevent the excessive bleeding the clotting disorder causes.
via Health News Headlines - Yahoo News http://ift.tt/1pkAkd3
via Health News Headlines - Yahoo News http://ift.tt/1pkAkd3
No comments:
Post a Comment